28 related articles for article (PubMed ID: 6503890)
1. Acute encephalopathy following the use of aluminum hydroxide in a boy affected with chronic kidney disease.
Malaki M
J Pediatr Neurosci; 2013 Jan; 8(1):81-2. PubMed ID: 23772257
[No Abstract] [Full Text] [Related]
2. Metabolism and possible health effects of aluminum.
Ganrot PO
Environ Health Perspect; 1986 Mar; 65():363-441. PubMed ID: 2940082
[TBL] [Abstract][Full Text] [Related]
3. Bone aluminum deposition in maintenance dialysis patients treated with aluminium-free dialysate: role of aluminium hydroxide consumption.
Heaf JG; Pødenphant J; Andersen JR
Nephron; 1986; 42(3):210-6. PubMed ID: 3945361
[TBL] [Abstract][Full Text] [Related]
4. Treatment of fracturing renal osteodystrophy by desferrioxamine.
Ackrill P; Day JP; Garstang FM; Hodge KC; Metcalfe PJ; Benzo Z; Hill K; Ralston AJ; Ball J; Denton J
Proc Eur Dial Transplant Assoc; 1983; 19():203-7. PubMed ID: 6878234
[TBL] [Abstract][Full Text] [Related]
5. Can low-dosage aluminium hydroxide control the plasma phosphate without bone toxicity?
Jenkins DA; Gouldesbrough D; Smith GD; Cowie JF; Winney RJ
Nephrol Dial Transplant; 1989; 4(1):51-6. PubMed ID: 2494599
[TBL] [Abstract][Full Text] [Related]
6. Calcium carbonate as a phosphate binder in dialysis patients: evaluation of an enteric-coated preparation and effect of additional aluminium hydroxide on hyperaluminaemia.
Ittel TH; Schäfer C; Schmitt H; Gladziwa U; Sieberth HG
Klin Wochenschr; 1991 Jan; 69(2):59-67. PubMed ID: 2027271
[TBL] [Abstract][Full Text] [Related]
7. [Hyperaluminemia in chronic hemodialysis patients. Evaluation of the respective roles of dialysate aluminum and oral aluminum hydroxide].
Tahiri Y; Moriniere P; Jaudon MC; Dkhissi H; Rosa A; Fournier A
Nephrologie; 1983; 4(3):129-33. PubMed ID: 6633778
[TBL] [Abstract][Full Text] [Related]
8. Serum aluminium in haemodialysis patients: relation to osteodystrophy, encephalopathy and aluminium hydroxide consumption.
Heaf JG; Nielsen LP
Miner Electrolyte Metab; 1984; 10(6):345-50. PubMed ID: 6503890
[TBL] [Abstract][Full Text] [Related]
9. [Osteodystrophy in children with chronic renal insufficiency in dialysis therapy].
Bartolozzi G; Pela I; Lavoratti GC; Bettucci E; Sirovich A; Pierattelli M; Materassi M
Pediatr Med Chir; 1982; 4(1-2):65-9. PubMed ID: 6287442
[TBL] [Abstract][Full Text] [Related]
10. Aluminum toxicity in relation to kidney disorders.
King SW; Savory J; Wills MR
Ann Clin Lab Sci; 1981; 11(4):337-42. PubMed ID: 7023347
[TBL] [Abstract][Full Text] [Related]
11. Aspects of aluminum toxicity.
Hewitt CD; Savory J; Wills MR
Clin Lab Med; 1990 Jun; 10(2):403-22. PubMed ID: 2197055
[TBL] [Abstract][Full Text] [Related]
12. Dementia in patients undergoing long-term dialysis: aetiology, differential diagnoses, epidemiology and management.
Rob PM; Niederstadt C; Reusche E
CNS Drugs; 2001; 15(9):691-9. PubMed ID: 11580308
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]